June 2, 2021
Heartseed CEO Keiichi Fukuda (left), Novo Nordisk Japan President Ole Moelskov Bech Heartseed, a biotech originating from Keio University, has won key allies at Novo Nordisk for the global development of its lead cell therapy asset HS-001, with the two...read more